http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060097335-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f74662d4d72e852ba1a027bba4a6588b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A46B2200-1066 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A46B17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A46B11-0037 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2005-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa31b9407d23885be25c5906cc2b2eeb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97891034320e970a736421c9c694a6fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6afcde84135d596fb8c2bb95fd61e6e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d56377980972daafaa39d54b0c0613cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83bf12961ba59567fe1ee58ff2bda4a6 |
| publicationDate | 2006-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20060097335-A |
| titleOfInvention | Validamycin Biosynthetic Gene Cluster and Primer thereof |
| abstract | The present invention relates to a biosynthetic gene cluster of antibiotic Validamycin and a primer capable of detecting the same, and dehydrogenase derived from Streptomyces hygroscopicus var. Limoneus KCTC1717. ) ValA, Aminotransferase ValB, Trehalose-phosphate synthase ValC, dTDP-4-keto-6-deoxyhexose reductase ValD, Ballylon Synthesis Determination of the gene sequence and amino acid sequence of the enzyme (2-epi-5-epi-valiolone synthase) ValE, Glucose-1-phosphate adenylyltransferase ValF provides an effect. In addition, physiologically active substances, including the valienamine structure, which is an intermediate of the biosynthesis of validamycin, have mainly alpha-glucosidase inhibition effect, which is why it is developed as an obesity treatment and pesticide in agriculture. As an important compound being developed, the enzymes for biosynthesizing the valenamine structure, that is, the dehydrogenase ValA, the amine transferase ValB, the ditipi keto deoxyhexose reductase (dTDP-4) The gene sequence and amino acid sequence of the -keto-6-deoxyhexose reductase) ValD, the 2-epi-5-epi-valiolone synthase ValE, are then screened for the bioactive-producing strains having a baliamine structure. In addition to the production of primers and DNA chips, it can be usefully applied for more effective production of validamycin or valenamine. Many effects can be expected.n n n n Streptomyces hygroscopius limoneus, validamycin, baliamine |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107245471-A |
| priorityDate | 2005-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 137.